http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003199494-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D223-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-16 |
| filingDate | 2001-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71ff1d9d7f02123bc13fc269d1e5ec7a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_108a657b61307d6419fd914289feba06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc67f9e5774e42923d1c7243ca2f6fd6 |
| publicationDate | 2003-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2003199494-A1 |
| titleOfInvention | 1,2,3,5-tetrahydrobenzo'c!azepin-4-one derivatives having muscarinic antagonist activity |
| abstract | There is disclosed a compound having the formula or a pharmaceutically acceptable salt thereof, wherein: R 1a , R 1b and R 1c are independently fluorine or hydrogen; R 2 is C 1 to C 12 alkyl being straight or branched chain, saturated or unsaturated, mono-substituted or unsubstituted, said substituents being selected from piperidine, pyrroliding, morpholine, thiomorpholine and cycloalkyl of 3 to 7 carbon atoms; a cycloalkyl of 3 to 9 carbon atoms; a cycloalkyl of 3 to 9 carbon atoms having a C 1 to C 6 alkyl substituent; a polycycloalkyl of 2 to 3 rings having 7 to 12 carbons; and phenyl or phenyl substituted with halogen, hydroxy, C 1 to C 6 alkoxy, C 1 to C 6 alkyl, nitro, methylene dioxy or trifluoromethyl; and R 3 is a moiety selected from: (I), (II) or a pyrrolidin-3-yl moiety of the formula (III). The compounds are disclosed for use as muscarinic antagonists with M 3 selectivity. |
| priorityDate | 2000-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 680.